Are you a patient diagnosed with bladder cancer, lung cancer, or melanoma — or a caregiver supporting someone with these conditions?
We invite you to participate in a short survey about your experiences, perceptions, concerns, and expectations regarding the use of artificial intelligence (AI) in cancer care. There are no right or wrong answers, and it does not aim to test technical knowledge: we are interested in your personal experience and point of view.
AI is a type of technology that can do tasks that normally need human intelligence. It helps doctors by analysing large amounts of medical information. In cancer care, AI can be used in several ways, for example:
• Reading medical images and suggesting what the diagnosis might be.
• Reviewing a patient’s medical data and recommending a treatment plan.
• Summarizing conversations between a patient and their doctor.
In all these cases, the AI gives suggestions that a doctor can either accept, modify or double-check before making a final decision.
This survey is part of the EU funded project called MULTIR. The goal of MULTIR is to make cancer treatments better by creating AI tools that help doctors provide more effective and personalized care. Your answers will help doctors and researchers design AI tools that truly match what patients and caregivers need and care about.
Taking part in this survey is voluntary, and all your answers will stay confidential.
The survey was created by experts in cancer care and AI and members of patient organisations. It’s divided into sections so we can understand what you think about different parts of cancer care.
The summary results of this survey will be published on the MULTIR website in 2026.
The survey will take 8-10 minutes approximately.
